Literature DB >> 11729248

Better preservation of peritoneal morphologic features and defense in rats after long-term exposure to a bicarbonate/lactate-buffered solution.

Liesbeth H P Hekking1, Mohammad Zareie1, Bas A J Driesprong1, Dirk Faict1, Angelique G A Welten1, Inge de Greeuw1, Inge L Schadee-Eestermans1, Carin E G Havenith1, Jacob van den Born1, Piet M Ter Wee1, Robert H J Beelen1.   

Abstract

The long-term effects of a standard lactate-buffered dialysis fluid and a new, two-chamber, bicarbonate/lactate-buffered dialysis fluid (with fewer glucose degradation products and a neutral pH) were compared in an in vivo peritoneal exposure model. Rats were given daily injections, via an access port, of 10 ml of standard solution or bicarbonate/lactate-buffered solution for 9 to 10 wk. The omentum, peritoneum, and mesothelial cell layer were screened for morphologic changes. In addition, the bacterial clearing capacity of the peritoneal cells was studied. Significantly more milky spots and blood vessels were observed in the omenta of animals treated with standard solution (P < 0.03 for both parameters). Electron-microscopic analysis demonstrated dramatic changes in the appearance of the vascular endothelial cells of the milky spots and a severely damaged or even absent mesothelium on the peritoneal membrane of the standard solution-treated animals. In contrast, the mesothelium was still present in the bicarbonate/lactate-buffered solution group, although the cells lost microvilli. Both peritoneal dialysis fluids significantly increased the density of mesothelial cells (per square millimeter) on the surface of the liver and the thickness of the submesothelial extracellular matrix of the peritoneum (both P < 0.04 for both fluids versus control). A significantly better ex vivo bacterial clearing capacity was observed with peritoneal cells from the bicarbonate/lactate-buffered solution group, compared with the standard solution group (P < 0.05 in both experiments). These results demonstrate that instillation of bicarbonate/lactate-buffered solution into rats for 9 to 10 wk preserves both morphologic and immune parameters much more effectively, compared with standard solution. These findings may be of considerable clinical importance.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11729248     DOI: 10.1681/ASN.V12122775

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  22 in total

1.  Cancer antigen 125 as a biomarker in peritoneal dialysis: mesothelial cell health or death?

Authors:  R T Krediet
Journal:  Perit Dial Int       Date:  2013 Nov-Dec       Impact factor: 1.756

Review 2.  A review of rodent models of peritoneal dialysis and its complications.

Authors:  Ji Wang; Shujun Liu; Hongyu Li; Jing Sun; Sijin Zhang; Xiaohong Xu; Yingying Liu; Yangwei Wang; Lining Miao
Journal:  Int Urol Nephrol       Date:  2014-11-26       Impact factor: 2.370

Review 3.  Strategies for preventing peritoneal fibrosis in peritoneal dialysis patients: new insights based on peritoneal inflammation and angiogenesis.

Authors:  Zhen Zhang; Na Jiang; Zhaohui Ni
Journal:  Front Med       Date:  2017-08-08       Impact factor: 4.592

Review 4.  Encapsulating peritoneal sclerosis: the state of affairs.

Authors:  Mario R Korte; Denise E Sampimon; Michiel G H Betjes; Raymond T Krediet
Journal:  Nat Rev Nephrol       Date:  2011-08-02       Impact factor: 28.314

5.  Buffer-dependent regulation of aquaporin-1 expression and function in human peritoneal mesothelial cells.

Authors:  Yihui Zhai; Jacek Bloch; Meike Hömme; Julia Schaefer; Thilo Hackert; Bärbel Philippin; Vedat Schwenger; Franz Schaefer; Claus P Schmitt
Journal:  Pediatr Nephrol       Date:  2012-03-01       Impact factor: 3.714

6.  Biocompatible Dialysis Solutions Preserve Peritoneal Mesothelial Cell and Vessel Wall Integrity. A Case-Control Study on Human Biopsies.

Authors:  Gloria del Peso; José Antonio Jiménez-Heffernan; Rafael Selgas; César Remón; Marta Ossorio; Antonio Fernández-Perpén; José Antonio Sánchez-Tomero; Antonio Cirugeda; Erika de Sousa; Pilar Sandoval; Raquel Díaz; Manuel López-Cabrera; María Auxiliadora Bajo
Journal:  Perit Dial Int       Date:  2015-10-16       Impact factor: 1.756

7.  Peritoneal Dialysis Catheter Increases Leukocyte Recruitment in the Mouse Parietal Peritoneum Microcirculation and Causes Fibrosis.

Authors:  Paulina M Kowalewska; Peter J Margetts; Alison E Fox-Robichaud
Journal:  Perit Dial Int       Date:  2015-10-16       Impact factor: 1.756

Review 8.  An update on peritoneal dialysis solutions.

Authors:  Elvia García-López; Bengt Lindholm; Simon Davies
Journal:  Nat Rev Nephrol       Date:  2012-02-21       Impact factor: 28.314

9.  Neuropeptide release augments serum albumin loss and reduces ultrafiltration in peritoneal dialysis.

Authors:  Nicola Cavallini; Dick Delbro; Gunnar Tobin; Magnus Braide
Journal:  Perit Dial Int       Date:  2011-09-30       Impact factor: 1.756

Review 10.  Peritoneal adipocytes and their role in inflammation during peritoneal dialysis.

Authors:  Kar Neng Lai; Joseph C K Leung
Journal:  Mediators Inflamm       Date:  2010-05-05       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.